![]() |
Order DONA™ through our new official corporate website: www.wynnpharm.com
![]()
|
||
DONA™ USA NEWS 64th American College of Rheumatology October 29 - November 2, 2000 * The independent, confirmatory evidence of the long term disease-modifying effect by Glucosamine Sulfate (DONA™) Glucosamine Sulfate decreases progression of knee osteoarthritis in a long-term,randomised, placebo-controlled,independent,confirmatory trial. * Follow-up studies to the former evidence of the disease-modifying effect by Glucosamine Sulfate (DONA™) Biochemical markers and Disease Modification Cartilage degradation in knee osteoarthrithis patients with elevated levels of urinary collagen type II C-Telopeptide fragments. Changes in serum osteocalcin but not other serum and urinary markers of bone and cartilage metabolism,measured after 12 months,are significantly correlated to long-term (36 months) structural changes in knee osteoarthritis (OA).. Biochemical markers of bone and cartilage remodeling are poorly correlated with clinical and radiological severity of knee osteoarthritis. * Efficacy of Glucosamine Sulfate (DONA™) on symptoms of OA at different joint localizations. Efficacy of Glucosamine Sulfate in osteoarthritis of the lumbar spine:a placebo-controlled, randomized,double-blind study.
|
||